According to what was reported, Sam German launched a competitor for the brain to compete with Musk’s Neuralink

The competition between Sam Al -Tamman and Eileon Musk is about to become strangers.

To date, the two were fighting his company with the most advanced artificial intelligence models. But soon, they can fight to prove those who make the best brain chip players.

I mentioned financial timesQuoted, unveiled sources, that the CEO of Openai Sam Altman is working to establish a new emerging e -starch company called Merge Labs. The company will develop what is known as the Brain computer interface (BCI). BCIS works by planting small electrodes that can read nerve signals in or near the brain. The primary goal of these devices is to allow humans to control digital devices with their ideas.

According to the Merge Labs, the money raised 850 million dollars, as most of the financing is expected to come from the startup fund at Openai, according to the Financial Times. Altman will help the company’s launch alongside Alex Blania, President of World ID, an emerging digital identifier company that controls the eyeball, as it supports Openai. Although Altman will be a co -founder, he is not expected to participate in his daily operations.

The new project will go to face with Elon Musk’s Brain Chip Startup Neuralink. According to Altman, Altman is that AI can give its chips an advantage over the current competitors.

Openai did not immediately respond to a request for comment from Gizmodo.

The company’s name seems to be due to a Sharing 2017 on Altman Personal Blog. In this, he described “integration”, which is the year in which humans and machines are integrated into one. At that time, he pointed out that most of the predictions at this moment ranged from 2025 to 2075, but he said that it had already started with social media algorithms that affect how people think and feel it.

Altman wrote: “Mercy can take a lot of models: We can connect the poles in our brains, or we can all become really close friends with Chatbot,” Altman wrote.

He added: “Although the merger has already begun, it will become more strange. We will be the first time ever to design our grandchildren.”

This year, in another post, Altman wrote about “Cute uniqueness,And it indicates that a penetration in the “high -end brain façades” can be above the horizon.

Musk’s Neuralink has a start. Founded in 2016, he has already received approvals from health organizers in multiple countries to start clinical trials. The company planted the chips in At least three patients With spinal cord injuries or als. The US Food and Drug Administration has been granted to the company’s penetration devices for its technology that aims to help people with them letter and vision Disabilities.

Musk and Altman participated in the founding of Openai, but Musk left in 2018 after the clashes with Altman flared up between the two. Musk has since launched the rival Amnesty International, Xai, and has been prosecuted to prevent Openai’s efforts to become a profitable company.

Only this week, the two The shots shot back and forth on x On Openai’s relationship with Apple and prominent position in the application store.